Danaher Schedules Fourth Quarter 2020 Earnings Conference Call

WASHINGTON, Jan. 7, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more

PerkinElmer to Acquire Oxford Immunotec Global PLC

PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 WALTHAM, Mass. & LONDON–(BUSINESS WIRE)–Jan. 7, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) (“Oxford Immunotec” or the “Company”) are pleased to announce they have reached an... Read more

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2 with support from the CDC. The combination of Illumina’s sequencing technology and expertise and Helix’s national COVID-19 testing footprint will significantly expand the country’s... Read more

Danaher Announces Executive Appointment

WASHINGTON, Dec. 21, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos (“JC”) Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos will have responsibility for helping define Danaher’s science and technology strategy across the organization, including facilitating innovation and further development of scientific and... Read more

alpha300 [i]apyron[/i] nominated for Best New Spectroscopy Product of 2020

WITec’s alpha300 apyron fully automated Raman microscope has been recognized by the SelectScience Scientists’ Choice Awards with a nomination in the category of “Best New Spectroscopy Product of 2020”. We’re very grateful to be in the running for this award, and sincerely appreciate the support that our customers have expressed for our most advanced microscope... Read more

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT®) Sequencing technology. Edinburgh Genomics, Oxford Genomics Centre,... Read more

PerkinElmer Launches MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits with Advanced Automation for Streamlined Mycotoxin Testing

Solution designed for complex matrices, delivering high sensitivity, single sample prep and high throughput processing   WHAT:   PerkinElmer , a global leader committed to innovating for a healthier world, today announced its MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits featuring automated Read more

WITec in Japan and the Chiba Institute of Technology, Japan, cooperate to analyze microplastics (< 20 µm)

WITec GmbH, the German manufacturer of high-performance Raman, AFM, SNOM, and correlative nano-analytical microscopy systems, announces a new cooperation in Japan for particle analysis. Dr. Yutaka Kameda, Associate Professor at the Chiba Institute of Technology (CIT) in Japan, and his team have been working very successfully for several years on the analysis of microplastics in... Read more

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced... Read more